ARCHX
Price
$17.26
Change
+$0.06 (+0.35%)
Updated
Apr 2 closing price
Net Assets
50.72M
CLBFX
Price
$34.25
Change
+$0.09 (+0.26%)
Updated
Apr 2 closing price
Net Assets
233.54B
Ad is loading...

ARCHX vs CLBFX

Header iconARCHX vs CLBFX Comparison
Open Charts ARCHX vs CLBFXBanner chart's image
Archer Balanced
Price$17.26
Change+$0.06 (+0.35%)
VolumeN/A
Net Assets50.72M
American Funds American Balanced 529F
Price$34.25
Change+$0.09 (+0.26%)
VolumeN/A
Net Assets233.54B
ARCHX vs CLBFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARCHX vs. CLBFX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCHX is a Buy and CLBFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 234B vs. ARCHX (50.7M). CLBFX pays higher dividends than ARCHX: CLBFX (2.14) vs ARCHX (1.32). ARCHX was incepted earlier than CLBFX: ARCHX (20 years) vs CLBFX (23 years). ARCHX (1.31) is less costly to investors than CLBFX (0.68). CLBFX is a more actively managed with annual turnover of: 171.00 vs. ARCHX (11.69). CLBFX has a lower initial minimum investment than ARCHX: CLBFX (250) vs ARCHX (2500). CLBFX annual gain was more profitable for investors over the last year : 3.62 vs. ARCHX (1.03). ARCHX return over 5 years is better than : 58.46 vs. CLBFX (51.73).
ARCHXCLBFXARCHX / CLBFX
Total Expense Ratio1.210.68178%
Annual Report Gross Expense Ratio1.310.68193%
Fund Existence20 years23 years-
Gain YTD-1.6610.202-823%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets50.7M234B0%
Annual Yield % from dividends1.322.1462%
Returns for 1 year1.033.6229%
Returns for 3 years10.1913.8574%
Returns for 5 years58.4651.73113%
Returns for 10 years66.3067.5198%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIUCX15.18N/A
N/A
JPMorgan Developed International Value C
MSSMX9.37N/A
N/A
Morgan Stanley Inst Inception A
QUASX54.41N/A
N/A
AB Small Cap Growth A
JUEPX23.18N/A
N/A
JPMorgan US Equity R3
ISFIX16.34N/A
N/A
VY® Columbia Contrarian Core I